ABVC BioPharma, Inc. (ABVC)

NASDAQ: ABVC · IEX Real-Time Price · USD
3.29
-0.04 (-1.20%)
At close: Jan 14, 2022 4:00 PM
3.42
0.13 (3.95%)
After-hours:Jan 14, 2022 4:02 PM EST
Market Cap94.12M
Revenue (ttm)455,783
Net Income (ttm)-9.75M
Shares Out28.61M
EPS (ttm)-0.42
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume101,622
Open3.25
Previous Close3.33
Day's Range3.25 - 3.43
52-Week Range1.95 - 11.69
Beta0.31
Analystsn/a
Price Targetn/a
Earnings DateNov 16, 2021

About ABVC

American BriVision (Holding) Corporation, a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, a combination therapy for triple negative breast cancer; ABV-1504 for major depressive disorders; ABV-1505 for attention deficit hyperactivity disorder; ABV-1703 for the treatment of pancreatic cancer; ABV-1702 to treat myelodysplastic syndromes; ABV-1601 for treating depression in cancer patients; and ABV-1701 Vitargus for the treatment ...

IndustryBiotechnology
IPO DateAug 3, 2021
Employees30
Stock ExchangeNASDAQ
Ticker SymbolABVC
Full Company Profile

Financial Performance

Financial Statements

News

ABVC BioPharma Selects Additional Vitargus® Phase II Study Sites

Thailand Sites Join Australian Sites Confirmed to Participate in the Study

1 week ago - GlobeNewsWire

ABVC BioPharma's Vitreous Substitute Vitargus Presented at 14th APVRS Congress

Fremont, CA, Dec. 22, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology...

3 weeks ago - GlobeNewsWire

ABVC BioPharma Medical Device Vitargus Receives Taiwan National Innovation Award

Fremont, CA, Dec. 15, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology...

1 month ago - GlobeNewsWire

Why ABVC BioPharma Shares Are Trading Higher On Friday?

ABVC BioPharma Inc (NASDAQ: ABVC) shares gained during the market trading session on continued momentum from yesterday's dietary supplement distribution deal and after a favorable report from Zacks Smal...

1 month ago - Benzinga

ABVC BioPharma Introduces Dietary Supplement Based on Maitake Mushroom, Enters into $3.0 Million Distribution Agreement

Fremont, CA, Dec. 09, 2021 (GLOBE NEWSWIRE) -- via  NewMediaWire --  ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematolo...

1 month ago - GlobeNewsWire

ABVC Biopharma Reports Third Quarter 2021 Financial and Operational Results

FREMONT, CA, Nov. 15, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (Nasdaq: ABVC), a biotechnology company specializing in botanically based solutions that deliver high efficacy wit...

2 months ago - GlobeNewsWire

ABVC Biopharma Receives Additional $4,245,000 from Exercise of Warrants, Total Capital from Public Offering Increases...

FREMONT, CA, Nov. 11, 2021 (GLOBE NEWSWIRE) -- via  NewMediaWire -- ABVC BioPharma, Inc.(Nasdaq: ABVC), a biotechnology company specializing in botanically based solutions that deliver high efficacy wit...

2 months ago - GlobeNewsWire

Hot Reddit Penny Stocks to Watch That Exploded Today

Check these Reddit penny stocks out for your watchlist in November The post Hot Reddit Penny Stocks to Watch That Exploded Today appeared first on Penny Stocks to Buy, Picks, News and Information | Penn...

Other symbols:ARTLFAMI
2 months ago - PennyStocks

ABVC Stock: The Social Media Chatter That Has ABVC BioPharma Shooting 250% Higher Today

ABVC BioPharma (ABVC) stock is rocketing higher on Monday as investors on social media hype up the shares despite a lack of news. The post ABVC Stock: The Social Media Chatter That Has ABVC BioPharma Sh...

2 months ago - InvestorPlace

ABVC Biopharma stock is up 275% on Monday: explained here

Shares of ABVC Biopharma Inc (NASDAQ: ABVC) are on fire this morning. The stock jumped nearly 300% on Monday as retail traders on StockTwits picked ABVC Biopharma as their next favourite.

2 months ago - Invezz

Central IRB Approved for ABV-1505 Phase II Part II in Taiwan Sites

ABVC BioPharma Receives Taiwan Regulatory Approval for ABV-1505 ADHD Phase II Part 2 Clinical Study

2 months ago - GlobeNewsWire

Why ABVC BioPharma Shares Are Trading Higher Today

ABVC BioPharma Inc (NASDAQ: ABVC) is trading higher Wednesday after the company announced new PCT filings for major depressive disorder (MDD) and attention-deficit hyperactivity disorder (ADHD) treatmen...

4 months ago - Benzinga

ABVC BioPharma Announces New PCT Filings for MDD and ADHD Treatments

FREMONT, CA, Sept. 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology...

4 months ago - GlobeNewsWire

ABVC BioPharma Report Updated by Zacks/SCR

FREMONT, CA, Aug. 30, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology,...

4 months ago - GlobeNewsWire

ABVC BioPharma Provides Vitargus® Update

FREMONT, CA, Aug. 26, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology,...

4 months ago - GlobeNewsWire

ABVC BioPharma Reports Second Quarter 2021 Results

Clinical Trials Continue Despite COVID-19 Restrictions

5 months ago - GlobeNewsWire

WallachBeth Capital Announces the Completion of an Underwritten Public Offering of 1,100,000 Units for ABVC BioPharma...

JERSEY CITY, N.J., Aug. 6, 2021 /PRNewswire/ -- WallachBeth Capital, a leading provider of capital markets and institutional execution services, announced the completion of an underwritten public offeri...

5 months ago - PRNewsWire

ABVC BioPharma, Inc. Announces Pricing of $6.875 Million Firm Commitment Offering

FREMONT, CA, Aug. 03, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, centra...

5 months ago - GlobeNewsWire

American BriVision Issues Shareholder Letter Outlining Achievements of 2020 and Outlook for 2021

via NewMediaWire  -- American BriVision (Holding) Corporation (OTCQB: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, central nervous system (C...

1 year ago - GlobeNewsWire